5594 |
MITOGEN-ACTIVATED PROTEIN KINASE 1 |
MAPK1 |
ERK |
ERK-2 |
ERK2 |
ERT1 |
MAPK2 |
P42MAPK |
PRKM1 |
PRKM2 |
p38 |
p40 |
p41 |
p41mapk |
p42-MAPK |
176948 |
6871 |
ENSG00000100030 |
OTTHUMG00000030508 |
1495 |
P28482 |
NP_002736 |
NM_002745 |
Extracellular signal-regulated kinase 2 |
MAP kinase isoform p42 |
Mitogen-activated protein kinase 2 |
MAP kinase 1 |
MAPK 1 |
MAP kinase 2 |
MAPK 2 |
MK01_HUMAN |
BE0000923 |
MITOGEN-ACTIVATED PROTEIN KINASE 1 (EC 2.7.1.37) (EXTRACELLULAR SIGNAL-REGULATED KINASE 2) (ERK-2) (MITOGEN-ACTIVATED PROTEIN KINASE 2) (MAP KINASE 2) (MAPK 2) (P42-MAPK) (ERT1). [SOURCE:UNIPROT/SWISSPROT;ACC:P28482] |
4532 |
PA30616 |
T58970 |
BE0009853 |
BE0009668 |
GuideToPharmacology Gene Category Name | ERK subfamily |
GuideToPharmacology Gene Category ID | 514 |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.24 |
Uniprot Evidence | 1: Evidence at protein level |
Uniprot Status | Swiss-Prot |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Interpro Acc | IPR002290 |
Human Readable Name | KINASE |
Interpro Type | Domain |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
Gene Biotype | PROTEIN_CODING |
KINASE |
SERINE THREONINE KINASE |
DRUG RESISTANCE |
TRANSCRIPTION FACTOR BINDING |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
ENZYME |
TRANSCRIPTION FACTOR |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
inhibitor (inhibitory) |
Details of the Assay for Interaction | Biochemical assay determination |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
inhibitor (inhibitory) |
Direct Interaction? | True |
Endogenous Drug? | False |
Specific Action of the Ligand | Inhibition |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
MAPK1 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
MAPK1 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.24 |
MITOGEN-ACTIVATED PROTEIN KINASE 1 (EC 2.7.1.37) (EXTRACELLULAR SIGNAL-REGULATED KINASE 2) (ERK-2) (MITOGEN-ACTIVATED PROTEIN KINASE 2) (MAP KINASE 2) (MAPK 2) (P42-MAPK) (ERT1). [SOURCE:UNIPROT/SWISSPROT;ACC:P28482] | Description |
ENSG00000100030 | Ensembl Gene Id |
MAPK1 | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
MAPK1 | Uniprot Gene Name |
MK01_HUMAN | Uniprot Id |
ENSG00000100030 | Ensembl Gene Id |
Uniprot Evidence | 1: Evidence at protein level |
Uniprot Status | Swiss-Prot |
Human Readable Name | DRUGGABLE GENOME |
KINASE, DRUGGABLE GENOME |
6871 | HUGO Gene ID |
6871 | HUGO Gene Symbol |
mitogen-activated protein kinase 1 | HUGO Gene Name |
GuideToPharmacology Gene Category Name | ERK subfamily |
GuideToPharmacology Gene Category ID | 514 |
ENZYME |
PA30616 | PharmGKB ID |
5594 | Entrez Gene ID |
4532 | CIViC Gene ID |
DRUG RESISTANCE |
MAPK1 | DrugBank Gene Name |
P28482 | UniProt Accession |
5594 | Entrez Gene Id |
MAPK1 | DrugBank Gene Name |
P28482 | UniProt Accession |
5594 | Entrez Gene Id |
MAPK1 | DrugBank Gene Name |
P28482 | UniProt Accession |
5594 | Entrez Gene Id |
ERK2 | TTD Gene Abbreviation |
T58970 | TTD Target ID |
ENSG00000100030 | Gene Symbol |
MAPK1 | Ensembl Id |
DRUGGABLE GENOME |
PRKM1 | GENE_SYMBOL |
PRKM2 | GENE_SYMBOL |
MAPK1 | GENE_SYMBOL |
Mitogen-activated protein kinase 1 | Gene Name |
P28482 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |
ERK2 | GO Gene Synonym |
PRKM1 | GO Gene Synonym |
PRKM2 | GO Gene Synonym |
KINASE, SERINE THREONINE KINASE, TRANSCRIPTION FACTOR BINDING |
MAPK1 | Gene Symbol |
CLINICALLY ACTIONABLE |
5594 | Gene ID |
ERK | dGene Synonym |
ERK2 | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |